Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine

Vaccine

Volumn 25, Issue 18, 2007, Pages 3588-3594

  Zeng, Mingtao ^a   Xu, Qingfu ^a   Pichichero, Michael E ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Anthrax vaccine; Bacillus anthracis; Mucosal immunization; Protective immunity

Indexed keywords

ANTHRAX VACCINE; ANTIBODY; ANTIGEN; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BACILLUS ANTHRACIS; CLINICAL PROTOCOL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; IMMUNITY; IMMUNIZATION; IN VITRO STUDY; LETHAL DOSE; LETHALITY; LYMPHOCYTE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SALIVA ANALYSIS; SERUM; VACCINATION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; FEMALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A, SECRETORY; MICE; MUCOUS MEMBRANE; TH1 CELLS; TH2 CELLS;

EID: 34147175134     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.075     Document Type: Article

References (29)

1. Mock M., and Fouet A. Anthrax. Annu Rev Microbiol 55 (2001) 647-671
2. Guarner J., Jernigan J.A., Shieh W.J., Tatti K., Flannagan L.M., Stephens D.S., et al. Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol 163 2 (2003) 701-709
3. Shieh W.J., Guarner J., Paddock C., Greer P., Tatti K., Fischer M., et al. The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax. Am J Pathol 163 5 (2003) 1901-1910
4. Brey R.N. Molecular basis for improved anthrax vaccines. Adv Drug Deliv Rev 57 9 (2005) 1266-1292 [Epub 2005 April 21]
5. Mahlandt B.G., Klein F., Lincoln R.E., Haines B.W., Jones Jr. W.I., and Friedman R.H. Immunologic studies of anthrax.IV. Evaluation of the immunogenicity of three components of anthrax toxin. J Immunol 96 4 (1966) 727-733
6. Welkos S., Little S., Friedlander A., Fritz D., and Fellows P. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology 147 Pt 6 (2001) 1677-1685
7. Anthrax Vaccine Adsorbed (BioThrax™) Product Insert. BioPort Corporation, Lansing, Michigan; 2002.
8. Friedlander A.M., Pittman P.R., and Parker G.W. Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax. JAMA 282 22 (1999) 2104-2106
9. Pittman P.R., Gibbs P.H., Cannon T.L., and Friedlander A.M. Anthrax vaccine: short-term safety experience in humans. Vaccine 20 5-6 (2001) 972-978
10. Pezard C., Weber M., Sirard J.C., Berche P., and Mock M. Protective immunity induced by Bacillus anthracis toxin-deficient strains. Infect Immun 63 4 (1995) 1369-1372
11. Little S.F. Anthrax vaccines: a development update. BioDrugs 19 4 (2005) 233-245
12. Price B.M., Liner A.L., Park S., Leppla S.H., Mateczun A., and Galloway D.R. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein. Infect Immun 69 7 (2001) 4509-4515
13. Galloway D., Liner A., Legutki J., Mateczun A., Barnewall R., and Estep J. Genetic immunization against anthrax. Vaccine 22 13-14 (2004) 1604-1608
14. Zeng M., Xu Q., Hesek E.D., and Pichichero M.E. N-fragment of edema factor as a candidate antigen for immunization against anthrax. Vaccine 24 January (5) (2006) 662-670 [Epub 2005 August 26]
15. Ezzell Jr. J.W., and Abshire T.G. Immunological analysis of cell-associated antigens of Bacillus anthracis. Infect Immun 56 2 (1988) 349-356
16. Cohen S., Mendelson I., Altboum Z., Kobiler D., Elhanany E., Bino T., et al. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun 68 8 (2000) 4549-4558
17. Brossier F., and Mock M. Toxins of Bacillus anthracis. Toxicon 39 11 (2001) 1747-1755
18. Wang J.Y., and Roehrl M.H. Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin. Med Immunol 4 1 (2005) 4
19. Kudva I.T., Griffin R.W., Garren J.M., Calderwood S.B., and John M. Identification of a protein subset of the anthrax spore immunome in humans immunized with the anthrax vaccine adsorbed preparation. Infect Immun 73 9 (2005) 5685-5696
20. Boyaka P.N., Tafaro A., Fischer R., Leppla S.H., Fujihashi K., and McGhee J.R. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen. J Immunol 170 11 (2003) 5636-5643
21. Welkos S.L., Keener T.J., and Gibbs P.H. Differences in susceptibility of inbred mice to Bacillus anthracis. Infect Immun 51 3 (1986) 795-800
22. Russell M.W., and Wu H.Y. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit. Infect Immun 59 11 (1991) 4061-4070
23. Pitt M.L., Little S.F., Ivins B.E., Fellows P., Barth J., Hewetson J., et al. In vitro correlate of immunity in a rabbit model of inhalational anthrax. Vaccine 19 32 (2001) 4768-4773
24. Hotomi M., Saito T., and Yamanaka N. Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin. Vaccine 16 20 (1998) 1950-1956
25. Jernigan J.A., Stephens D.S., Ashford D.A., Omenaca C., Topiel M.S., Galbraith M., et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 7 6 (2001) 933-944
26. Abramova F.A., Grinberg L.M., Yampolskaya O.V., and Walker D.H. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci USA 90 6 (1993) 2291-2294
27. Vasconcelos D., Barnewall R., Babin M., Hunt R., Estep J., Nielsen C., et al. Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis). Lab Invest 83 8 (2003) 1201-1209
28. Cote C.K., Rossi C.A., Kang A.S., Morrow P.R., Lee J.S., and Welkos S.L. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions. Microb Pathog 38 5-6 (2005) 209-225 [Epub 2005 April 22]
29. Kenney R.T., Yu J., Guebre-Xabier M., Frech S.A., Lambert A., Heller B.A., et al. Induction of protective immunity against lethal anthrax challenge with a patch. J Infect Dis 190 4 (2004) 774-782 [Epub 2004 July 13]